Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2062 - Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma:A Prospective, Single Arm, Phase II Study (FUTURE-2)
Speaker: Fan, Xingwen, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2063 - Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Study
Speaker: Fan, Xingwen, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2064 - Upfront Intracranial Brachytherapy Using Cs-131 Followed by External Beam Radiation Therapy vs. Stupp Protocol: A Pilot Voxel-by-Voxel Biological Effective Dose Comparison Accounting for Tumor Repopulation in Glioblastoma Patients
Speaker: Ferreira, Clara, PhD - University of Minnesota, Minneapolis, MN
3:00 PM - 4:00 PM ET

2065 - Treatment Related Factors and Survival Determinants in Pleomorphic Xanthoastrocytoma
Speaker: Feyisa, Jilcha, MD, MPH - Dartmouth-Hitchcock Medical Center, Lebanon, NH
3:00 PM - 4:00 PM ET

2066 - Re-Treatment with <sup>177</sup>Lu-edotreotide in Patients with Progressive NETs: A SwissNET Registry Analysis
Speaker: Fricke, Julia - University Hospital Basel, Basel, Basel-Stad
3:00 PM - 4:00 PM ET

2067 - Superior Hippocampal Sparing with Spiral VMAT in Whole-Brain Radiotherapy: A Dosimetric Comparison
Speaker: Gao, Yue - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi
3:00 PM - 4:00 PM ET

2068 - Investigating Prognostic Value of Diffusion Weighted MRI for Patients with High Grade Glioma Undergoing PULSAR Reirradiation
Speaker: Gard, Gabrielle, BS - University of Texas Southwestern Medical Center, Dallas, TX
3:00 PM - 4:00 PM ET

2069 - Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study
Speaker: Zheng, Xiaoli, MD - The affiliated cancer hospital of Zhengzhou University, Zhengzhou, Henan
3:00 PM - 4:00 PM ET

2070 - Survival Outcomes of Adjuvant Immunotherapy after Neoadjuvant Chemoimmunotherapy Followed by Esophagectomy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Speaker: Zheng, Xiaoli, MD - The affiliated cancer hospital of Zhengzhou University, Zhengzhou, Henan
3:00 PM - 4:00 PM ET

2071 - The Role of Tumor-Infiltrating Clonal Hematopoiesis and Frailty in Outcomes for Patients with IDH-Wildtype Glioblastoma
Speaker: Ghaseminezhad, Homayoun - University of Washington, Seattle, WA
3:00 PM - 4:00 PM ET

2072 - Initial Experience of Modern External Beam Dose Escalation in the Setting of Total Neoadjuvant Therapy for Rectal Cancer
Speaker: Gill, Gobind, MD - University of Alabama at Birmingham, Birmingham, AL
3:00 PM - 4:00 PM ET

2073 - Robotic-Arm Linear Accelerator Radiotherapy for Vestibular Schwannomas: A Single-Institution Experience
Speaker: Goc, Bartlomiej, MD - National Oncology Institute of Maria Sklodowska-Curie – National Research Institute (Gliwice branch), Gliwice